Mandatory labeling requirements and over-the-counter cough and cold medication use in early childhood

OBJECTIVES: Due to rare but severe adverse events, Health Canada in October 2009 required manufacturers to relabel over-the-counter (OTC) cough and cold medication (CCM) to state that the products should not be used in children

Saved in:
Bibliographic Details
Published in:Canadian journal of public health 2015-11, Vol.106 (8), p.e477-e482
Main Authors: Degroot, Julie, Anderson, Laura N., Chen, Yang, Birken, Catherine S., Parkin, Patricia C., Carsley, Sarah, Khovratovich, Marina, Mamdani, Muhammad, Maguire, Jonathon L.
Format: Article
Language:English
Subjects:
Age
Age Factors
Canada
Child, Preschool
Children
Children & youth
Cohort Studies
Common Cold - drug therapy
Cough
Cough - drug therapy
Diseases
Drug Labeling - legislation & jurisprudence
Families & family life
Family Characteristics
Female
Health care
Humans
Infant
Influenza, Human - drug therapy
Interrupted Time Series Analysis
Labeling
Male
Mandatory Programs
Maternal age
Medical errors
Medications
Medicine & Public Health
Modeling
Mothers - statistics & numerical data
Nonprescription drugs
Nonprescription Drugs - therapeutic use
Parents & parenting
Pediatrics
Pharmaceutical research
Preschool children
Public Health
QUANTITATIVE RESEARCH
Referents
Surveys and Questionnaires
Time series
Urban Population - statistics & numerical data
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVES: Due to rare but severe adverse events, Health Canada in October 2009 required manufacturers to relabel over-the-counter (OTC) cough and cold medication (CCM) to state that the products should not be used in children
ISSN:0008-4263
1920-7476
DOI:10.17269/CJPH.106.5148